Apollo Hospitals announced the launch of cutting-edge clinical genomic tests from the Strand Center for Genomics and Personalized Medicine, a part of Strand Life Sciences across its hospital network. These tests in oncology, cardiovascular, heritable eye diseases and rare genetic disorders shall be integrated into clinical practice by Apollo’s...
HCG partners with Strand Life Sciences to integrate genomics as a ‘standard of care’ in cancer treatment and risk prediction.Cancer treatment adapted for Indian genomic variations.Affordable tests that improve precision treatment decisions and clinical outcomes in cancer care. HealthCare Global (HCG) Enterprises Ltd, The Specialists in Cancer...
Strand Life Sciences (Strand), a Bangalore and San Francisco-based bioinformatics and systems biology company has received patent protection for its “method for predicting organ toxicity and a system thereof” in the United States (USPTO patent no. 8,645,075) effective from 4 February 2014. The method is currently employed in the form of...
